Neuroleptic malignant syndrome related to a switch to perospirone and anticholinergic withdrawal.
Tanii
Hisashi
H
Fujita
Kohei
K
Okazaki
Yuji
Y
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D054833:Isoindoles; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D012563:Schizophrenia, Paranoid / Q000188:drug therapy / Q000523:psychology; D013375:Substance Withdrawal Syndrome / Q000209:etiology*; D013844:Thiazoles / Q000009:adverse effects* / Q000627:therapeutic use
D014150:Antipsychotic Agents; D018680:Cholinergic Antagonists; D007211:Indoles; D054833:Isoindoles; D013844:Thiazoles; C065533:perospirone